INFORMATION BY CANCER TYPE
Genetics may play a role in chemotherapy-related fatigue, according to a recent study.
A number of patients with lung cancer have benefitted from immunotherapy agents, and researchers in the field are excited that these treatments will continue to improve the field.
A more personalized approach is needed in treatment plans for patients with stage 3 non-small cell lung cancer (NSCLC), according to Thomas A. Hensing, M.D.
Tagrisso (osimertinib) was granted a Breakthrough Therapy Designation for the firstline treatment of patients who have metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC).
Snapshots of emotions experienced and lessons learned from a mid-20s, Chinese-American daughter of a patient.
Immunotherapy combinations are inducing higher and more durable responses for patients with non-small cell lung cancer (NSCLC), sparking excitement in the oncology community.
Alunbrig (brigatinib) was granted a supplemental new drug application for the treatment of patients with non-small cell lung cancer (NSCLC). Now, the drug can be administered via 180-mg tablets.
Expanding surveillance after surgery from chest X-ray to follow-up with PET-CT scan did not improve overall survival (OS), researchers reported during the 2017 ESMO Congress.
The Food and Drug Administration approved the first ever biosimilar to treat a variety of cancers.
Stroke survivors were diagnosed with cancer at almost double the rate of incidence in the general population, one study showed.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Non-Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of non-small cell lung cancer.
Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of small cell lung cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Lung Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Lung Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for lung cancer.